Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
23 participants
OBSERVATIONAL
2012-02-29
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The clinical standard for measuring energy needs is the use of indirect calorimeter.The indirect calorimeter takes individualized measurements for each patient and therefore will enable dietitians and clinicians to provide sufficient calories in the diet to better manage the disease and promote normal growth and development.
We believe daily energy requirements will vary within metabolic diseases (Phenylketonuria) and mitochondrial disorders (mitochondrial fatty acid oxidation defect, POLG1 mutation etc.).
The objective of this preliminary study is to measure resting energy expenditure in children living with metabolic and mitochondrial conditions and data obtained will be used to generate future hypothesis and will form a basis for future studies.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder
NCT01471652
Therapy for Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder
NCT01872351
Study of the Metabolism of Pyruvate and Related Problems in Patients With Lactic Acidemia
NCT00004353
Nutritional Therapy of the Deficits of Oxidation Mitochondrial of the Fatty Acids
NCT00328159
Effects of Carnitine Supplementation on Liver and Muscle
NCT03439917
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Metabolic Disease- Phenylketonuria
No interventions assigned to this group
Mitochondrial disorder
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Children(1-18y) who are not diagnosed with PKU or a mitochondrial disorder
* Children(1-18y) who are diagnosed with either PKU or a mitochondrial disorder, but are currently experiencing illness such as fever, cold, vomiting or diarrhea
1 Year
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rare Disease Foundation, Vancouver, Canada
OTHER
University of British Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rajavel Elango, PhD
Principle Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rajavel Elango, PhD
Role: PRINCIPAL_INVESTIGATOR
Child & Family Research Institute/University of British Columbia
Sylvia Stockler-Ipsiroglu
Role: STUDY_CHAIR
University of British Columbia/Faculty of Pediatrics
Ramona Meni Salvarinova Zivkovic
Role: STUDY_CHAIR
University of Bristish Columbia/Faculty of Pediatrics
Howard Parsons
Role: STUDY_CHAIR
University of British Columbia/Faculty of Pediatrics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Child & Family Research Institute
Vancouver, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H11-02094
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.